Lipella Pharmaceuticals | 10-Q:2024财年三季报
Lipella Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Michele Gruber(3.9%)
Lipella Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Leaf Huang(5.7%)
Lipella Pharmaceuticals | DEF 14A:股东委托书决议
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | PRE 14A:并购重组委托声明
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Michael B. Chancellor(16.0%)
Lipella Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Jonathan H. Kaufman(16.2%)
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Michael B. Chancellor(18.8%)
Lipella Pharmaceuticals | D:发行公告
Lipella Pharmaceuticals | 10-Q:2024财年二季报
Lipella Pharmaceuticals | ARS:年度报告
Lipella Pharmaceuticals | DEF 14A:股东委托书决议
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | 8-K:重大事件
Lipella Pharmaceuticals | 424B5:募资说明书
暂无数据
暂无数据